Literature DB >> 30601055

Practice variation in total hip arthroplasty versus hemiarthroplasty for treatment of fractured neck of femur in Australia.

I A Harris1, A Cuthbert1, R de Steiger1, P Lewis1, S E Graves1.   

Abstract

AIMS: Displaced femoral neck fractures (FNF) may be treated with partial (hemiarthroplasty, HA) or total hip arthroplasty (THA), with recent recommendations advising that THA be used in community-ambulant patients. This study aims to determine the association between the proportion of FNF treated with THA and year of surgery, day of the week, surgeon practice, and private versus public hospitals, adjusting for known confounders. PATIENTS AND METHODS: Data from 67 620 patients in the Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) from 1999 to 2016 inclusive were used to generate unadjusted and adjusted analyses of the associations between patient, time, surgeon and institution factors, and the proportion of FNF treated with THA.
RESULTS: Overall, THA was used in 23.7% of patients. THA was more frequently used over time, in younger patients, in healthier patients, in cases performed on weekdays (adjusted odds ratio (OR) 1.27; 95% confidence interval (CI) 1.14 to 1.41), in private hospitals (adjusted OR 4.34; 95% CI 3.94 to 4.79) and by surgeons whose hip arthroplasty practice has a relatively higher proportion of elective patients (adjusted OR 1.65; 95% CI 1.49 to 1.83).
CONCLUSION: Practice variation exists in the proportion of FNF patients treated with THA due to variables other than patient factors. This may reflect variation in resources available and surgeon preference, and uncertainty regarding the relative indication.

Entities:  

Keywords:  Femoral neck fractures; Hemiarthroplasty; Total hip arthroplasty

Mesh:

Year:  2019        PMID: 30601055     DOI: 10.1302/0301-620X.101B1.BJJ-2018-0666.R1

Source DB:  PubMed          Journal:  Bone Joint J        ISSN: 2049-4394            Impact factor:   5.082


  6 in total

1.  Geographic variation in hip fracture surgery rate, care quality and outcomes: a comparison between national registries in Ireland and Denmark.

Authors:  Mary E Walsh; Jan Sorensen; Catherine Blake; Søren Paaske Johnsen; Pia Kjær Kristensen
Journal:  Arch Osteoporos       Date:  2022-09-26       Impact factor: 2.879

2.  Hip fracture care and national systems: Australia and Asia.

Authors:  Seth M Tarrrant; Amit Ajgaonkar; Sushrut Babhulkar; Zhiyong Cui; Ian A Harris; Sunil Kulkarni; Hiroaki Minehara; Takashi Miyamoto; Andrew Oppy; Kenji Shigemoto; Yun Tian; Zsolt J Balogh
Journal:  OTA Int       Date:  2020-03-23

3.  Comparison of Mortality, Length of Hospital Stay and Transfusion between Hemiarthroplasty and Total Hip Arthroplasty in Octo- and Nonagenarian Patients with Femoral Neck Fracture: a Nationwide Study in Korea.

Authors:  Jun-Il Yoo; Suk-Yong Jang; Yonghan Cha; Won-Sik Choy; Kyung-Hoi Koo
Journal:  J Korean Med Sci       Date:  2021-11-22       Impact factor: 2.153

4.  Dual mobility versus conventional total hip arthroplasty in femoral neck fractures (DISTINCT): protocol for a registry-nested, open-label, cluster-randomised crossover trial.

Authors:  John E Farey; Tamara Hooper; Tania Alland; Justine M Naylor; Thu-Lan Kelly; Michelle Lorimer; Adriane M Lewin; Margaret Rogers; Chi Kin Law; Jacqueline Close; Steven E Graves; Richard S de Steiger; Peter L Lewis; Sam Adie; Ian A Harris
Journal:  BMJ Open       Date:  2022-09-21       Impact factor: 3.006

5.  Fragility Fracture Systems: International Perspectives - Asia & Australia.

Authors:  Seth M Tarrant; Ji Wan Kim; Takashi Matsushita; Hiroaki Minehara; Tomoyuki Noda; Jong-Keon Oh; Ki Chul Park; Noriaki Yamamoto; Zsolt J Balogh
Journal:  OTA Int       Date:  2022-06-09

6.  Epidemiology, classification, treatment, and mortality of adult femoral neck and basicervical fractures: an observational study of 40,049 fractures from the Swedish Fracture Register.

Authors:  Jonas Sundkvist; Anders Brüggeman; Arkan Sayed-Noor; Michael Möller; Olof Wolf; Sebastian Mukka
Journal:  J Orthop Surg Res       Date:  2021-09-15       Impact factor: 2.359

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.